LANTHANUM CARBONATE
Generic: LANTHANUM CARBONATE
Cipla USA Inc.Manufacturer
ORALRoute
LANTHANUM CARBONATEActive Substance
2022-01-24Original Approval
LANTHANUM CARBONATE is FDA application ANDA206868, sponsored by INVAGEN PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2025-10-24
Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen PFailed stability specifications: Out of specification for hardness test
Class II2025-10-24
Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen PFailed stability specifications: Out of specification for hardness test
Top Reported Reactions
1
GENERAL PHYSICAL HEALTH DETERIORATION
261 reports
2
NAUSEA
259 reports
3
SEPSIS
259 reports
4
HYPONATRAEMIA
258 reports
5
OFF LABEL USE
256 reports
6
VOMITING
256 reports
7
MULTIPLE ORGAN DYSFUNCTION SYNDROME
253 reports
8
ABDOMINAL DISTENSION
248 reports
9
ABDOMINAL PAIN
244 reports
10
STRESS
244 reports